Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes

Journal of Cellular Physiology

Volumn 180, Issue 2, 1999, Pages 271-284

  Zeigler, Mary E ^a   Chi, Yiqing ^a   Schmidt, Tanja ^a,b   Varani, James ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EXTRACELLULAR REGULATED PROTEIN KINASE; GELATINASE B; JUN N TERMINAL KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL INVASION; CELL MOTILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; LIVER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGEN-ANTIBODY COMPLEX; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COLLAGENASES; EPIDERMAL GROWTH FACTOR; EPIDERMIS; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KERATINOCYTES; KINETICS; LUCIFERASES; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 0032990608     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199908)180:2<271::AID-JCP15>3.0.CO;2-D     Document Type: Article

References (50)

1. 2-terminal kinase pathway in rat skeletal muscle. J Biol Chem 272:25636-25640.
2. 3 mediates chemotactic and haptotatic motility in human melanoma cells through different signaling pathways. J Biol Chem 271:3247-3254.
3. Bottaro DP, Rubin JS, Faletto DL, Chan A, Kniecick TE, Vande Woude GP, Aaronson SA. 1991. Identification of the hepatocyte growth factor receptor as the c-met protooncogene. Science 251: 802-804.
4. Boyce ST, Ham RG. 1983. Calcium regulated differentiation of normal human epidermal keratinocytes in chemically-defined clonal culture and in serum-free serial culture. J Invest Dermatol 81:33-40.
5. Camussi G, Montrucchio G, Lupia E, Soldi R, Comoglio PM, Bussolino F. 1997. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol 158:1302-1309.
6. Cavigelli M, Dolfi F, Claret FX, Karin M. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14:5957-5964.
7. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. 1988. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541-552.
8. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. 1992. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708.
9. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
10. Doerr ME, Jones JI. 1996. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor 1-stimulated chemotaxis of human breast cancer cells. J Biol Chem 27:2443-2447.
11. Fligiel SEG, Varani J. 1993. In situ epithelial cell invasion in organ culture. Invasion Metastasis 13:225-233.
12. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE. 1995a. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14:951-962.
13. Gille H, Strahl T, Shaw PE. 1995b. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr Biol 5:1191-1200.
14. Giordano S, Zhen Z, Medico E, Goudino G, Galimi F, Comoglio PM. 1993. Transfer of motogenic and invasive response to scatter factor/ hepatocyte growth factor by transfection of human MET protoooncogene. Proc Natl Acad Sci USA 90:649-653.
15. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672-10680.
16. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. 1997. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14:1481-1493.
17. Gutman A, Wasylyk B. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246.
18. Hartmann G, Naldini L, Weidner KM, Sachs M, Vigna E, Comoglio PM, Birchmeier W. 1992. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-MET receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA 89:11574-11578.
19. Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB. 1996. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest 97:2541-2552.
20. Hunter T, 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225-236.
21. Jiang Y, Chan JL, Zong CS, Wang LH. 1996. Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth receptor. J Biol Chem 271: 160-167.
22. Karin M, Liu ZG, Zandi E. 1997. AP-1 function and regulation. Curr Opin Cell Biol 9:240-246.
23. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. 1997. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492.
24. Komada M, Kitamura N. 1993. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-MET receptor. Oncogene 8:2381-2390.
25. Liotta LA, Abe S, Robey PG, Martin GR. 1979. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci USA 76:2268-2272.
26. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA. 1990. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 144:326-332.
27. McCawley LJ, O'Brien P, Hudson LG. 1997. Overexpression of the epidermal growth factor receptor contributes to enhanced ligand-mediated motility in keratinocyte cell lines. Endocrinology 138: 121-127.
28. Pang L, Sawada T, Decker SJ, Salteil AR. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
29. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84:6379-6383.
30. Price JT, Wilson HM, Haites NE. 1996. Epidermal growth factor (EGF) increases the in vitro invasion, motility, and adhesion interactions of the primary renal carcinoma cell line A704. Eur J Cancer 32:1977-1982.
31. Quinones S, Buttice G, Kurkinen M. 1994. Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J 302:471-477.
32. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, AAronson S, Vande Woude G. 1992. Tumorigenicity of the met proto-oncogene and the gene for the hepatocyte growth factor. Mol Cell Biol 12:5152-5158.
33. Sato H, Seiki M. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405.
34. Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H. 1995. Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 104:958-963.
35. Schramek H, Schumacher M, Pfaller W. 1996. Sustained ERK-2 activation in rat glomerular mesangial cells: differential regulation by protein phosphatases. Am J Physiol 271:F423-F432.
36. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:762-735.
37. Smeal T, Angel P, Meek J, Karin M. 1989. Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes Dev 3:2091-2100.
38. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573.
39. Symes K, Mercola M. 1996. Embryonic mesoderm cells spread in response to platelet-derived growth factor and signaling by phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 93:9641-9644.
40. 2-terminal kinase. Proc Natl Acad Sci USA 94:7337-7342.
41. Traverse S, Gomez N, Paterson H, Marchall C, Cohen P. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288:351-355.
42. Traverse S, Seedorf K, Marshall CJ, Cohen P, Ullrich A. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4:694-701.
43. 2+ differentially influence extracellular matrix production by human skin in organ culture. Am J Pathol 142:1813-1822.
44. Varani J, Perone P, Inman DR, Burmeister W, Schollenberger SB, Fligiel SEG, Sitrin RS, Johnson KJ. 1995. Human skin in organ culture. Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors. Am J Pathol 146:210-217.
45. Weidner KM, Sachs M, Birchmeier W. 1993. The MET receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 121:145-154.
46. Whisler RL, Chen M, Beiqing L, Carle KW. 1997. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Cell Immunol 175:41-50.
47. 2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc Natl Acad Sci USA 94:3004-3009.
48. Yao Z, Diener K, Wang XS, Zukowski M, Matsumoto G, Zhou G, Mo R, Sasaki T, Nishina H, Hui CC, Tan TH, Woodgett JP, Penninger JM. 1997. Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase (MKK7). J Biol Chem 272: 32378-32383.
49. Zeigler ME, Krause S, Karmiol S, Varani J. 1996a. Growth factor-induced epidermal invasion of the dermis in human skin organ culture: dermal invasion correlated with epithelial cell motility. Invasion Metastasis 16:3-10.
50. Zeigler ME, Dutcheshen NT, Gibbs DF, Varani J. 1996b. Growth factor-induced epidermal invasion of the dermis in human skin organ culture: expression and role of matrix metalloproteinases. Invasion Metastasis 16:11-18.